[1] |
纪怡璠, 滕振杰, 李向雨, 等. 脑小血管病患者核磁总负荷与同型半胱氨酸的相关性[J]. 中华行为医学与脑科学杂志, 2020, 29(3):233-238.
|
[2] |
JI Y, LI X, TENG Z, et al. Homocysteine is associated with the development of cerebral small vessel disease:retrospective analyses from neuroimaging and cognitive outcomes[J]. J Stroke Cerebrovasc Dis, 2020, 29(12):105393.
DOI
URL
|
[3] |
LEEUWIS A E, HOOGHIEMSTRA A M, BRON E E, et al. Cerebral blood flow and cognitive functioning in patients with disorders along the heart-brain axis:cerebral blood flow and the heart-brain axis[J]. Alzheimers Dement(N Y), 2020, 6(1):e12034.
|
[4] |
BRANDHOFE A, STRATMANN C, SCHÜRE J R, et al. T2 relaxation time of the normal-appearing white matter is related to the cognitive status in cerebral small vessel disease[J]. J Cereb Blood Flow Metab, 2021, 41(7):1767-1777.
DOI
URL
|
[5] |
QIN Y, ZHU W, LIU C, et al. Functional brain connectome and its relation to mild cognitive impairment in cerebral small vessel disease patients with thalamus lacunes:a cross-sectional study[J]. Medicine(Baltimore), 2019, 98(40):e17127.
|
[6] |
王学颖, 王洪权, 赵伟丽. 脑小血管病患者认知功能障碍与血尿酸、同型半胱氨酸水平相关性研究[J]. 神经损伤与功能重建, 2019, 14(7):360-361.
|
[7] |
WONG F C C, YATAWARA C, LOW A, et al. Cerebral small vessel disease influences hippocampal subfield atrophy in mild cognitive impairment[J]. Transl Stroke Res, 2021, 12(2):284-292.
DOI
|
[8] |
梁军华, 贾建平. 血管性痴呆、血管性认知障碍国际分类、诊断标准概述及2011年中国血管性认知障碍分类诊断标准解读[C]. 北京:第四届全国痴呆与认知障碍学术研讨会及高级讲授班论文汇编, 2015.
|
[9] |
倪俊, 徐运. 脑小血管病转化医学研究中国专家共识[J]. 中国卒中杂志, 2018, 13(8):853-870.
|
[10] |
王征宇, 张明园. 中文版简易智能状态检查(MMSE)的应用[J]. 上海精神医学, 1989, 7(3):108-111.
|
[11] |
LIANG Y, CHEN Y K, LIU Y L, et al. Cerebral small vessel disease burden is associated with accelerated poststroke cognitive decline:a 1-year follow-up study[J]. J Geriatr Psychiatry Neurol, 2019, 32(6):336-343.
DOI
URL
|
[12] |
王雅楠, 姚琳, 毛文静, 等. 脑小血管病患者氧化应激标志物,磁共振总负担与血管性认知障碍的相关性[J]. 中华行为医学与脑科学杂志, 2020, 29(10):898-903.
|
[13] |
ZHANG J, LIU N, YANG C. Effects of rosuvastatin in combination with nimodipine in patients with mild cognitive impairment caused by cerebral small vessel disease[J]. Panminerva Med, 2019, 61(4):439-443.
DOI
PMID
|
[14] |
ZHONG X, YAN X, LIANG H, et al. Evaluation of eight-style Tai chi on cognitive function in patients with cognitive impairment of cerebral small vessel disease:study protocol for a randomised controlled trial[J]. BMJ Open, 2021, 11(2):e042177.
DOI
URL
|
[15] |
王雅楠, 牛雪芬, 范少凯, 等. 缺血性脑小血管病患者凝血标志物及同型半胱氨酸与血管性认知障碍的相关性[J]. 中华老年心脑血管病杂志, 2020, 22(3):281-284.
|
[16] |
ZHANG X, LIU X, XIA R, et al. Chinese herbal medicine for vascular cognitive impairment in cerebral small vessel disease:a protocol for systematic review and meta-analysis of randomized controlled trials[J]. Medicine(Baltimore), 2020, 99(40):e22455.
|
[17] |
WANG Y, YANG Y, WANG T, et al. Correlation between white matter hyperintensities related gray matter volume and cognition in cerebral small vessel disease[J]. J Stroke Cerebrovasc Dis, 2020, 29(12):105275.
DOI
URL
|
[18] |
赵留庄, 杨智越, 王丽娟. 脑小血管病致认知功能障碍的相关危险因素研究[J]. 中国临床医生杂志, 2019, 47(5):564-567.
|
[19] |
ZHAO W, ZHU X Q, LIU H, et al. Effects of left heart function changes on cerebral small vessel diseases and its cognitive impairment[J]. Natl Med J China, 2019, 99(13):971-976.
|
[20] |
TURON M, ABRAIRA L, CAZORLA S, et al. Vascular risk factors as independent predictors of neurocognitive impairments in patients with late-onset epilepsy who have small-vessel disease[J]. Epilepsy Behav, 2020, 104(Pt B):106443.
|
[21] |
ZHU S, WEI X, YANG X, et al. Plasma lipoprotein-associated phospholipase A2 and superoxide dismutase are independent predicators of cognitive impairment in cerebral small vessel disease patients:diagnosis and assessment[J]. Aging Dis, 2019, 10(4):834-846.
DOI
URL
|
[22] |
王结群, 吴毅泰, 王星, 等. 脑小血管病总负荷与记忆力下降老年患者认知功能,脑萎缩及脑灌注的相关性[J]. 中国卒中杂志, 2020, 15(12):1276-1280.
DOI
|